India's semiconductor ambition is no longer just government rhetoric. It's playing out in the quarterly results of three very different companies—Cyient Limited, CG Power and Industrial Solutions, and Acutaas Chemicals. Each is betting big on a different slice of the chip value chain, and each is grappling with the same fundamental problem: the money goes out now, but the profits come later, much later.
Cyient's semiconductor segment posted a net loss of ₹45.2 crore in Q2 FY27, widening from ₹34.2 crore in the previous quarter. The culprit isn't operational inefficiency—it's deliberate, front-loaded investment.
Strip that out, and the core business is roughly breaking even. Transcript +1
The company is betting heavily on high-voltage power chips for AI data centers and electric vehicles. These chips are still in development, with customer samples expected by late 2026 or early 2027 and substantial revenue targeted for FY28. Until then, Cyient is burning cash to build something it hopes will become a proprietary product franchise. Transcript +1
The path to FY28 breakeven hinges on two things. First, the new high-voltage products must actually ship. Second, the company needs to expand its power management content per unit. While specific figures weren't confirmed in official documents, the logic is straightforward: if Cyient can sell more value per chip, revenue grows faster than the fixed R&D cost base, eventually flipping the EBIT margin from its current negative 16.2% into positive territory. Investor Presentation
But there are risks. Foundries are running at full capacity, pushing up wafer prices and lengthening planning cycles. Rising memory costs are also weighing on demand. Management has warned that these supply constraints could push the breakeven timeline out by a quarter or two. That's a problem for a stock trading at a premium 31.5x P/E despite a declining ROE of 8.4%. Transcript +1
CG Power's semiconductor story is about scale, not just chips. The company is investing ₹7,600 crore to build an Outsourced Semiconductor Assembly and Test (OSAT) facility at Sanand, Gujarat. The G1 plant is operational at 5 lakh chips per day, with G2 set to take total capacity to 145 lakh chips per day by late 2026. Other
The gap between spending and earning is stark. CG Semi reported FY26 revenue of just ₹0.42 crore against a loss before tax of ₹80.28 crore. Commercial production at G2 isn't expected until late FY28 or FY29. This creates a multi-year funding void. Other
However, the risk is heavily shared.
That's roughly 65% of the project cost covered by government support on a pari-passu basis. CG Power's own equity exposure is therefore much smaller than the headline ₹7,600 crore figure. Annual Report
The drag on current profitability is real but manageable. Semiconductor investments cost the consolidated PBT about ₹35 crore (91 basis points) in Q2 FY27. But this is easily absorbed by the Power Systems division, which saw PBT jump 44% year-on-year to ₹559 crore, with margins expanding 430 basis points to 25%. The strong order book of ₹23,646 crore provides the cash flow to fund the semiconductor dream without breaking the bank.
The market is clearly looking through the current losses. CG Power trades at a staggering 95.7x P/E, pricing in not just the Power Systems growth but also the long-term option value of a domestic semiconductor champion.
Acutaas is taking a different route. It's not making chips; it's making the ultra-pure chemicals that go into them. The company claims to be India's only manufacturer of semiconductor-grade photoresist chemicals through its 55% subsidiary, Baba Fine Chemicals. Investor Presentation
Its strategy is a clever dual-hub model.
This puts Acutaas right next to major customers in Korea and Japan, bypassing the skepticism that often greets new suppliers in this quality-obsessed industry.
The South Korea plant, inaugurated in August 2026, is expected to start contributing revenue from FY28. Management has guided for revenue of about 1x the ₹200 crore capex at maturity, implying a significant new revenue stream. The company is also expanding its customer base in Japan, South Korea, and Taiwan. Transcript +1
Acutaas trades at a 74.3x P/E, supported by a recovering ROE of 24% and ROCE of 28.3%. The premium assumes the company can sustain high margins (guidance of 38–40% EBITDA) and successfully execute the Korea ramp-up. Any delay in customer qualification or margin pressure would test this valuation.
None of this would be happening without the India Semiconductor Mission. Semicon 2.0, approved in July 2026 with an outlay of ₹1.27 lakh crore, explicitly covers design, materials, fabs, ATMP/OSAT, R&D, and talent. For CG Power, this means direct fiscal support that de-risks the OSAT project. For Cyient and Acutaas, it creates a supportive ecosystem and potential future incentives under the design and materials pillars.
Twelve manufacturing projects worth over ₹1.64 lakh crore have been approved so far, including fabs, OSAT units, and packaging facilities. This pipeline creates domestic demand for everything Cyient, CG Power, and Acutaas are trying to build.
Investing in semiconductors is a test of patience. Cyient needs its high-voltage chips to ship on time. CG Power needs to fill its massive OSAT capacity with qualified customers. Acutaas needs to prove its chemicals can meet the exacting standards of global chipmakers.
The government has provided the runway. Now, these three companies have to prove they can fly.
